Parameter explainer · Shape

Morphology: the shape score, and why it worries people more than it should

Morphology is the most misunderstood number on the report. It is also the most subjective and, on its own, the least predictive. Here is what it measures, where your value sits, and what the evidence says it changes.

What morphology measures

Morphology is the share of sperm in a sample that have a "textbook" shape: an oval head, a midpiece, and one straight tail with no visible defects. A trained technician stains a few hundred sperm and scores each one by eye. Under the strict criteria used today, most sperm in every man, fertile or not, do not qualify.[2]

100 sperm as 100 little men

2textbook

Interactive. The values 4, 14 and 32 are the WHO 2021 5th, 50th and 90th centiles for men whose partners conceived within a year.[1]

Where your value sits

The WHO 2021 reference population is roughly 3,500 fertile men. One in twenty of them had fewer than 4% normal forms, half had fewer than 14%, and one in ten had more than 32%.[1] The manual itself states that the 5th centile alone is not sufficient to diagnose infertility.[2]

WHO 2021 distribution for normal forms. The coral marker shows an example value of 2%. Enter your own in the numbers box.
Centile5th25th50th75th95th
Normal forms4%9%14%20%36%

Why two labs can disagree

Morphology is the most subjective number on the report. When 62 technicians from 42 laboratories scored the same 100 projected sperm, the share they called normal ranged from 6% to 39%, a spread of 40% around the reference answer of 7%. Assessors who handled many samples and used standard methods came closest.[3] Labs also differ in which criteria they apply; the strict (Tygerberg) system that produced the 4% limit is far harsher than the systems behind the 30–50% figures some older sources still quote.[4]

Practical consequence: a 2% from one lab and a 4% from another may describe the same sample. Ask which criteria the lab used and how many cells were counted before comparing two reports.

What it predicts, and what it does not

Natural conception

In the classic comparison of 696 fertile and 765 infertile couples, strict morphology above 12% was "fertile range," below 9% "subfertile range", yet the authors stressed the overlap was so large that no single measure is diagnostic.[7] In the LIFE cohort of 501 couples stopping contraception, abnormal morphology was linked to slightly longer time to pregnancy only until sperm count was accounted for; it was not an independent predictor.[5] Among 24 men with 0% normal forms, 29% conceived without assisted reproduction, and every one of them who conceived naturally went on to have another child naturally.[5]

IUI

A meta-analysis of 20 studies and 21,018 insemination cycles found pregnancy rates of 14.2% per cycle with 4% or more normal forms and 12.1% below it; at the 1% threshold, 14.0% versus 13.9%. Neither difference was significant.[5] In 1,287 cycles from a single centre, rates were essentially flat across morphology bands (15.6% at 1% or lower, 14.9% above 14%); low morphology mattered only when the number of motile sperm inseminated fell below 5 million.[6]

IVF and ICSI

Older conventional-IVF series reported lower fertilization below 4% normal forms, but ICSI series repeatedly show no difference, including 39% pregnancy per cycle with 0% normal forms and 70% fertilization when no morphologically normal sperm were available at all.[5] Both recent reviews reach the same conclusion: morphology has limited independent prognostic value and should not be used alone to steer a couple toward IVF or ICSI.[4][5] Rare uniform defects such as globozoospermia (all round heads) are the exception and need specialist counselling.

The AUA/ASRM guideline has no statement about morphology on its own. Its Statement 9 says results carry the most weight when several parameters are abnormal together.

Why the repeat test matters

Sperm take an average of 64 days (range 42–76) from the start of production to ejaculation, measured directly in healthy men.[8] A sample today reflects conditions two to three months ago. On top of that biology, within-man variation is large: in 74 men giving 5 to 20 samples each, the within-subject coefficient of variation for count was 54%, and the authors concluded that at least three samples are needed to characterize a man reliably.[9] Both major guidelines ask for at least two analyses, ideally a month apart, when the first is abnormal.[10][11]

What can lower it

FactorWhat the evidence showsStrength
Scoring method and assessor6–39% spread on identical sperm; strict criteria lower all scores.[3]High
SmokingNormal forms 1.37 points lower in smokers across 20 studies and 5,865 men; larger in heavier smokers.[12]Moderate (observational)
Clinical varicoceleRepair associated with roughly +3 points normal forms in pooled studies; pregnancy effect low-certainty.[14]Low to moderate
Scrotal heat (sauna, hot tubs, fever)Count and motility impaired after 3 months of twice-weekly sauna, fully reversed within 6 months; morphology data weaker.Low
Uniform genetic defectsGlobozoospermia, macrozoospermia: a single abnormality in nearly every cell.[5]Specialist

What guidelines say to do next

  1. Repeat the analysis, same lab if possible, about a month later.[10]
  2. Read morphology alongside concentration and motility. Isolated low morphology with normal count and motility is the lowest-concern pattern.[10]
  3. Physical exam for varicocele. If one is palpable and semen parameters are abnormal, repair should be considered; subclinical varicoceles are not repaired (AUA/ASRM Statements 26–27; EAU Strong).[10][11]
  4. Lifestyle risks may be discussed, with the caveat that data for most are limited (Statement 8).[10]
  5. Supplements: the guideline calls the benefit "of questionable clinical utility" and names no agent (Statement 45). Cochrane's 2022 review found a very-low-certainty live-birth signal that disappeared when high-risk-of-bias trials were excluded.[10][13]
  6. Sperm DNA fragmentation testing is not recommended in the initial evaluation (Statement 16).[10]

Ask for a prompt specialist review if: the report describes 0% normal forms with one uniform defect (all round heads, all large heads); morphology is low together with low count and low motility; concentration is below 5 million/mL; or there is any scrotal mass, pain, or size difference.

Questions to bring to your doctor

  • Which morphology criteria did the lab use (WHO 2021 strict, or an older system), and how many sperm were counted?
  • Is morphology the only value below the reference, or are concentration and motility also low?
  • Given my count and motility, how much does this one number change the plan?
  • Should the repeat test be at the same lab, and when?
  • Did you examine for a varicocele? If one is present, is it palpable or only visible on ultrasound?
  • If we consider IUI, what post-wash motile count would you expect, and is it above 5 million?
  • Is there a pattern in the abnormal forms (all the same defect) that would change the advice?
  • What, specifically, would you expect a lifestyle change to move, and when would we see it?

Things people hear, and what the evidence says

"2% means 98% of my sperm are defective."
Under strict criteria the median fertile man has 14% normal forms. "Not textbook" is not the same as "cannot fertilize."
"Low morphology means go straight to IVF or ICSI."
Large IUI and ICSI datasets show no outcome difference by morphology alone; guidelines weigh several abnormalities together, not this one number.
"My morphology went from 1% to 4%, so the supplements worked."
Scoring spread on identical sperm is 6–39% between assessors. A 1 to 4 change is within measurement noise unless count and motility moved too.
"Low morphology causes birth defects."
A 984-cycle IUI study found no relationship between teratozoospermia and birth abnormalities or miscarriage.

Sources

Each claim above carries a bracketed number pointing here. "Primary" means the full paper or guideline text was read; "abstract" means the abstract; "via review" means the figure was taken from a named review.

  1. WHO 6th-edition reference distributions (Campbell et al. 2021), reproduced in PMC — primary table. https://pmc.ncbi.nlm.nih.gov/articles/PMC12539902/table/t1/
  2. Boitrelle F et al. The sixth edition of the WHO manual: a critical review. Life 2021 — primary. https://pmc.ncbi.nlm.nih.gov/articles/PMC8706130/
  3. Auger J et al. Intra- and inter-individual variability in human sperm morphology assessment. Hum Reprod 2003 — abstract. https://academic.oup.com/humrep/article/18/5/1018/652378
  4. Mohammad Nouh et al. Isolated teratozoospermia: narrative review. Transl Androl Urol 2024 — primary. https://tau.amegroups.com/article/view/121952/html
  5. Review of sperm morphology and clinical outcomes (incl. Kohn 2018 meta-analysis, LIFE study, Kovac 2017). Reprod Med Biol 2024 — primary review. https://onlinelibrary.wiley.com/doi/full/10.1002/rmb2.12594
  6. Low morphology and IUI outcomes by inseminated motile count; 1,287 cycles. PLOS ONE 2025 — primary. https://pmc.ncbi.nlm.nih.gov/articles/PMC11922279/
  7. Guzick DS et al. Sperm morphology, motility and concentration in fertile and infertile men. NEJM 2001 — primary. https://www.nejm.org/doi/full/10.1056/NEJMoa003005
  8. Misell LM et al. Human spermatogenesis kinetics in vivo. J Urol 2006 — abstract. https://pubmed.ncbi.nlm.nih.gov/16406920/
  9. Keel BA. Within- and between-subject variation in semen parameters. Fertil Steril 2006 — abstract. https://pubmed.ncbi.nlm.nih.gov/16412742/
  10. AUA/ASRM Guideline on Male Infertility (2024 amendment) — primary. https://www.auanet.org/guidelines-and-quality/guidelines/male-infertility
  11. EAU Guidelines: Male Infertility — primary. https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/male-infertility
  12. Sharma R et al. Cigarette smoking and semen quality: meta-analysis. Eur Urol 2016 — abstract. https://pubmed.ncbi.nlm.nih.gov/27113031/
  13. de Ligny W et al. Antioxidants for male subfertility. Cochrane 2022 — primary. https://pmc.ncbi.nlm.nih.gov/articles/PMC9066298/
  14. Persad E et al. Surgical or radiological treatment for varicoceles in subfertile men. Cochrane 2021 — abstract. https://pubmed.ncbi.nlm.nih.gov/33890288/